NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/16/2025
Back to search
Official data from USPTO
ALGERNON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
86
Latest update
12/17/2025
Trademark type
Word
Nice classes
5
Filing date
07/09/2019
Registration date
12/16/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/16/2025
Last transaction
12/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
VANCOUVER, BC, CA
Examiner
FRIEDMAN,LESLEE ANN
Law office
N20
Current location
INTENT TO USE SECTION
Holders and representatives
Holders
ALGERNON PHARMACEUTICALS INC.
Breathtec Biomedical Inc.
Representatives
Nicholas J. Gingo RENNER, OTTO, BOISSELLE & SKLAR, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for use in the treatment of kidney diseasesliver diseasesinflammatory bowel diseases and pulmonary diseases namely coughs and lung cancer
Publications
History of USPTO decisions and trademark events.
86 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/16/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
11/21/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/21/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/01/2025
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
10/01/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/26/2025
EX1G
SOU EXTENSION 1 GRANTED
04/25/2025
EXT1
SOU EXTENSION 1 FILED
04/25/2025
EEXT
SOU TEAS EXTENSION RECEIVED
04/25/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/29/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/03/2024
PUBO
PUBLISHED FOR OPPOSITION
09/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/14/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/29/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
07/29/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/29/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
07/29/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/29/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/29/2024
GNFR
FINAL REFUSAL E-MAILED
04/29/2024
CNFR
FINAL REFUSAL WRITTEN
04/29/2024
DOCK
ASSIGNED TO EXAMINER
04/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/26/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/23/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/23/2024
CNSI
SUSPENSION INQUIRY WRITTEN
01/23/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/10/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/02/2023
GNSL
LETTER OF SUSPENSION E-MAILED
06/02/2023
CNSL
SUSPENSION LETTER WRITTEN
06/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/31/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
03/06/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/06/2023
CNSI
SUSPENSION INQUIRY WRITTEN
03/06/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/04/2022
GNSL
LETTER OF SUSPENSION E-MAILED
08/04/2022
CNSL
SUSPENSION LETTER WRITTEN
08/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/28/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/28/2022
ALIE
ASSIGNED TO LIE
07/28/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/26/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
07/20/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
07/20/2022
CNSI
SUSPENSION INQUIRY WRITTEN
07/20/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/24/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/03/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/02/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/02/2021
GNSL
LETTER OF SUSPENSION E-MAILED
09/02/2021
CNSL
SUSPENSION LETTER WRITTEN
09/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/01/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/25/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/02/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/02/2021
CNSI
SUSPENSION INQUIRY WRITTEN
08/02/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/22/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/21/2020
GNSL
LETTER OF SUSPENSION E-MAILED
09/21/2020
CNSL
SUSPENSION LETTER WRITTEN
09/21/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/15/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/15/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/11/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/29/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/29/2020
CNSI
SUSPENSION INQUIRY WRITTEN
04/29/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/29/2020
ALIE
ASSIGNED TO LIE
04/28/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/18/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/07/2019
GNSL
LETTER OF SUSPENSION E-MAILED
10/07/2019
CNSL
SUSPENSION LETTER WRITTEN
10/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/03/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
10/02/2019
GPRA
PRIORITY ACTION E-MAILED
10/02/2019
CPRA
PRIORITY ACTION WRITTEN
10/02/2019
DOCK
ASSIGNED TO EXAMINER
09/25/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/16/2019
NWAP
NEW APPLICATION ENTERED
07/12/2019
Continuous trademark protection
Get notified about every new filing that threatens ALGERNON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.